Levodopa/Benserazide 200/50 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Levodopa/Benserazide 200/50 mg, covering 2017-03-31 to 2017-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg [Phase 1]